关注
Antonis Fanouriakis
Antonis Fanouriakis
在 med.uoa.gr 的电子邮件经过验证
标题
引用次数
引用次数
年份
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
A Fanouriakis, M Kostopoulou, A Alunno, M Aringer, I Bajema, JN Boletis, ...
Annals of the rheumatic diseases 78 (6), 736-745, 2019
19432019
2019 update of the joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the …
A Fanouriakis, M Kostopoulou, K Cheema, HJ Anders, M Aringer, ...
Annals of the rheumatic diseases 79 (6), 713-723, 2020
7702020
Update οn the diagnosis and management of systemic lupus erythematosus
A Fanouriakis, N Tziolos, G Bertsias, DT Boumpas
Annals of the rheumatic diseases 80 (1), 14-25, 2021
6082021
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
A Fanouriakis, M Kostopoulou, J Andersen, M Aringer, L Arnaud, SC Bae, ...
Annals of the rheumatic diseases 83 (1), 15-29, 2024
2482024
Diagnostic criteria for systemic lupus erythematosus: has the time come?
GK Bertsias, C Pamfil, A Fanouriakis, DT Boumpas
Nature Reviews Rheumatology 9 (11), 687-694, 2013
1812013
Pathogenic and therapeutic relevance of JAK/STAT signaling in systemic lupus erythematosus: integration of distinct inflammatory pathways and the prospect of their inhibition …
A Alunno, I Padjen, A Fanouriakis, DT Boumpas
Cells 8 (8), 898, 2019
1462019
Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, Greece
I Gergianaki, A Fanouriakis, A Repa, M Tzanakakis, C Adamichou, ...
Annals of the rheumatic diseases 76 (12), 1992-2000, 2017
1402017
Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity
NI Panousis, GK Bertsias, H Ongen, I Gergianaki, MG Tektonidou, ...
Annals of the rheumatic diseases 78 (8), 1079-1089, 2019
1192019
In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for …
C Adamichou, D Nikolopoulos, I Genitsaridi, A Bortoluzzi, A Fanouriakis, ...
Annals of the rheumatic diseases 79 (2), 232-241, 2020
1032020
Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells
M Nakou, ED Papadimitraki, A Fanouriakis, GK Bertsias, C Choulaki, ...
Clin Exp Rheumatol 31 (2), 172-179, 2013
1002013
Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus
C Adamichou, I Genitsaridi, D Nikolopoulos, M Nikoloudaki, A Repa, ...
Annals of the rheumatic diseases 80 (6), 758-766, 2021
862021
Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus …
A Fanouriakis, C Adamichou, S Koutsoviti, S Panopoulos, C Staveri, ...
Seminars in arthritis and rheumatism 48 (3), 467-474, 2018
842018
EULAR recommendations for neuropsychiatric systemic lupus erythematosus vs usual care: results from two European centres
C Pamfil, A Fanouriakis, L Damian, M Rinzis, P Sidiropoulos, G Tsivgoulis, ...
Rheumatology 54 (7), 1270-1278, 2015
762015
Pathogenesis and treatment of CNS lupus
A Fanouriakis, DT Boumpas, GK Bertsias
Current opinion in rheumatology 25 (5), 577-583, 2013
762013
Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant …
M Kostopoulou, A Fanouriakis, K Cheema, J Boletis, G Bertsias, D Jayne, ...
RMD open 6 (2), e001263, 2020
612020
Changing paradigms in the treatment of systemic lupus erythematosus
A Fanouriakis, G Bertsias
Lupus Science & Medicine 6 (1), e000310, 2019
592019
Neuropsychiatric lupus or not? Cerebral hypoperfusion by perfusion-weighted MRI in normal-appearing white matter in primary neuropsychiatric lupus erythematosus
E Papadaki, A Fanouriakis, E Kavroulakis, D Karageorgou, ...
Annals of the rheumatic diseases 77 (3), 441-448, 2018
592018
Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-centre study
A Fanouriakis, C Pamfil, P Sidiropoulos, L Damian, A Flestea, G Gusetu, ...
Lupus 25 (6), 627-636, 2016
592016
Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset …
D Nikolopoulos, M Kostopoulou, A Pieta, T Karageorgas, D Tseronis, ...
Lupus 29 (5), 514-522, 2020
582020
Cerebrovascular events in systemic lupus erythematosus: diagnosis and management
D Nikolopoulos, A Fanouriakis, DT Boumpas
Mediterranean journal of rheumatology 30 (1), 7-15, 2019
562019
系统目前无法执行此操作,请稍后再试。
文章 1–20